$246 Million is the total value of AIGH Capital Management LLC's 86 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COHU | New | COHU INC | $22,144,000 | – | 580,000 | +100.0% | 9.00% | – |
| OIIM | New | O2MICRO INTERNATIONAL LIMITEspons adr | $16,783,000 | – | 1,828,199 | +100.0% | 6.82% | – |
| BLBD | New | BLUE BIRD CORP | $14,961,000 | – | 819,360 | +100.0% | 6.08% | – |
| CLDR | New | CLOUDERA INC | $13,910,000 | – | 1,000,000 | +100.0% | 5.65% | – |
| FFIV | New | F5 NETWORKS INC | $13,196,000 | – | 75,000 | +100.0% | 5.36% | – |
| New | FORD MTR CO DELcall | $13,185,000 | – | 1,500,000 | +100.0% | 5.36% | – | |
| AVYA | New | AVAYA HLDGS CORP | $12,639,000 | – | 660,000 | +100.0% | 5.13% | – |
| EMKR | New | EMCORE CORP | $12,592,000 | – | 2,310,364 | +100.0% | 5.12% | – |
| COHR | New | COHERENT INC | $11,823,000 | – | 78,808 | +100.0% | 4.80% | – |
| NLS | New | NAUTILUS INC | $11,808,000 | – | 650,970 | +100.0% | 4.80% | – |
| ASPN | New | ASPEN AEROGELS INC | $10,945,000 | – | 655,819 | +100.0% | 4.45% | – |
| OBCI | New | OCEAN BIO CHEM INC | $8,179,000 | – | 612,222 | +100.0% | 3.32% | – |
| LPTH | New | LIGHTPATH TECHNOLOGIES INC | $7,269,000 | – | 1,854,324 | +100.0% | 2.95% | – |
| New | IDEAL PWR INC | $6,160,000 | – | 753,970 | +100.0% | 2.50% | – | |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $4,794,000 | – | 274,583 | +100.0% | 1.95% | – |
| PRTK | New | PARATEK PHARMACEUTICALS INC | $4,692,000 | – | 749,608 | +100.0% | 1.91% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $4,592,000 | – | 349,463 | +100.0% | 1.86% | – |
| CPRX | New | CATALYST PHARMACEUTICALS INC | $4,511,000 | – | 1,350,554 | +100.0% | 1.83% | – |
| SBBP | New | STRONGBRIDGE BIOPHARMA PLC | $4,287,000 | – | 1,764,173 | +100.0% | 1.74% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $3,793,000 | – | 875,851 | +100.0% | 1.54% | – |
| ANVS | New | ANNOVIS BIO INC | $3,497,000 | – | 463,797 | +100.0% | 1.42% | – |
| SCPH | New | SCPHARMACEUTICALS INC | $3,372,000 | – | 637,322 | +100.0% | 1.37% | – |
| MYO | New | MYOMO INC | $2,918,000 | – | 433,569 | +100.0% | 1.18% | – |
| NMTR | New | 9 METERS BIOPHARMA INC | $2,676,000 | – | 3,115,000 | +100.0% | 1.09% | – |
| CBIO | New | CATALYST BIOSCIENCES INC | $2,657,000 | – | 421,042 | +100.0% | 1.08% | – |
| ALNA | New | ALLENA PHARMACEUTICALS INC | $2,560,000 | – | 2,000,000 | +100.0% | 1.04% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $2,456,000 | – | 701,700 | +100.0% | 1.00% | – |
| New | ALIMERA SCIENCES INC | $2,114,000 | – | 501,025 | +100.0% | 0.86% | – | |
| ARDS | New | ARIDIS PHARMACEUTICALS INC | $2,107,000 | – | 347,016 | +100.0% | 0.86% | – |
| EDAP | New | EDAP TMS S Asponsored adr | $2,063,000 | – | 398,912 | +100.0% | 0.84% | – |
| AVNW | New | AVIAT NETWORKS INC | $2,028,000 | – | 59,382 | +100.0% | 0.82% | – |
| HEPA | New | HEPION PHARMACEUTICALS INC | $2,022,000 | – | 923,230 | +100.0% | 0.82% | – |
| PXLW | New | PIXELWORKS INC | $1,882,000 | – | 667,120 | +100.0% | 0.76% | – |
| CYTHW | New | CYCLO THERAPEUTICS INC*w exp 11/14/202 | $1,523,000 | – | 350,000 | +100.0% | 0.62% | – |
| CYTH | New | CYCLO THERAPEUTICS INC | $1,523,000 | – | 350,000 | +100.0% | 0.62% | – |
| THTX | New | THERATECHNOLOGIES INC | $1,442,000 | – | 576,814 | +100.0% | 0.59% | – |
| SLRX | New | SALARIUS PHARMACEUTICALS INC | $1,370,000 | – | 1,505,985 | +100.0% | 0.56% | – |
| CLRBZ | New | CELLECTAR BIOSCIENCES INC*w exp 04/20/202 | $1,228,000 | – | 583,037 | +100.0% | 0.50% | – |
| EFOI | New | ENERGY FOCUS INC | $1,126,000 | – | 279,535 | +100.0% | 0.46% | – |
| NDRA | New | ENDRA LIFE SCIENCES INC | $975,000 | – | 1,300,000 | +100.0% | 0.40% | – |
| DAIO | New | DATA I O CORP | $820,000 | – | 198,845 | +100.0% | 0.33% | – |
| ACER | New | ACER THERAPEUTICS INC | $656,000 | – | 250,518 | +100.0% | 0.27% | – |
| KTCC | New | KEY TRONIC CORP | $327,000 | – | 47,353 | +100.0% | 0.13% | – |
| PBLA | New | PANBELA THERAPEUTICS INC | $320,000 | – | 89,730 | +100.0% | 0.13% | – |
| VUZI | New | VUZIX CORP | $238,000 | – | 26,159 | +100.0% | 0.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AVIAT NETWORKS INC | 12 | Q3 2023 | 6.8% |
| SCPHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| THERATECHNOLOGIES INC | 11 | Q2 2023 | 2.9% |
| FRANKLIN WIRELESS CORP | 11 | Q3 2023 | 2.9% |
| IDEAL PWR INC | 11 | Q3 2023 | 2.5% |
| MEDICENNA THERAPEUTICS CORP | 11 | Q3 2023 | 1.1% |
| PARATEK PHARMACEUTICALS INC | 10 | Q1 2023 | 3.2% |
| LIGHTPATH TECHNOLOGIES INC | 10 | Q3 2023 | 3.0% |
| MYOMO INC | 10 | Q3 2023 | 1.3% |
| DZS INC | 9 | Q1 2023 | 7.5% |
View AIGH Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Bridgeline Digital, Inc. | May 21, 2021 | 627,419 | 9.7% |
View AIGH Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-12 |
View AIGH Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.